Testing a protein test to diagnose bile duct cancer
Part of Cancer clinical trials.
This study is testing if a new protein-based lab test can better identify bile duct cancer from stored tissue samples. It's looking for people who had a bile duct sample taken but don't yet have a clear cancer diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have a narrowing in the bile duct that doctors aren't sure is cancer.
- You've already had a tissue sample taken from the bile duct to check for cancer, and that sample is saved in a wax block.
- Pancreatic cancer has not been found in your bile duct sample or through other tests.
- You are not under any form of legal guardianship or protection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
This study looks at a protein called plectin on the surface of cells to see if it can help diagnose bile duct cancer using samples taken during a routine ERCP procedure. If you already need an ERCP for a narrowed or blocked bile duct, this may help improve cancer detection.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.